The carbapenem-based antibiotics market size is expected to grow from US$ 3,964.57 million in 2021 to US$ 5,346.62 million by 2028; it is estimated to grow at a CAGR of 4.4% during 2021-2028.

The Carbapenem-Based Antibiotics Market is growing due to rising multidrug-resistant bacterial infections and increasing healthcare-associated infections. These broad-spectrum antibiotics are vital for treating severe infections. Market growth is driven by advancing R&D, rising hospitalizations, and expanding healthcare infrastructure, despite challenges like regulatory scrutiny and the need for antibiotic stewardship programs.

Source: The Insight Partners